866 filings
424B5
DRRX
Durect Corp
28 Mar 24
Prospectus supplement for primary offering
5:26pm
10-K
2023 FY
DRRX
Durect Corp
Annual report
28 Mar 24
4:52pm
8-K
DRRX
Durect Corp
27 Mar 24
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:15pm
SC 13G
DRRX
Durect Corp
27 Mar 24
DURECT / INGALLS & SNYDER ownership change
3:15pm
8-K
DRRX
Durect Corp
22 Mar 24
Other Events
4:05pm
8-K
DRRX
Durect Corp
4 Mar 24
DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZETĀ® Product Line in U.S. and Canada
11:37am
SC 13G
DRRX
Durect Corp
16 Feb 24
DURECT / ASEN R SCOTT ownership change
4:09pm
SC 13G/A
DRRX
Durect Corp
14 Feb 24
DURECT / Lion Point Capital ownership change
4:16pm
8-K
DRRX
Durect Corp
22 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
SC 13G/A
DRRX
Durect Corp
1 Dec 23
DURECT / Bleichroeder ownership change
4:28pm
10-Q
2023 Q3
DRRX
Durect Corp
Quarterly report
14 Nov 23
12:00am
8-K
DRRX
Durect Corp
13 Nov 23
DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update
4:15pm
8-K
DRRX
Durect Corp
7 Nov 23
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial
4:10pm
8-K
DRRX
Durect Corp
7 Sep 23
DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial
9:02am
S-8
DRRX
Durect Corp
10 Aug 23
Registration of securities for employees
4:21pm
10-Q
2023 Q2
DRRX
Durect Corp
Quarterly report
10 Aug 23
4:18pm
8-K
DRRX
Durect Corp
9 Aug 23
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update
4:23pm
8-K
DRRX
Durect Corp
21 Jul 23
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
5:13pm
424B5
DRRX
Durect Corp
21 Jul 23
Prospectus supplement for primary offering
10:38am
4
Robertson Judith J.
23 Jun 23
DURECT / Judith J. Robertson ownership change
5:33pm